Technology area: Biotechnology & Pharmaceuticals
4 pending office actions • 3 art units • 3 examiners • 0 of 4 (0%) have an AI response strategy ready
Georgiamune Inc. is managing 4 pending office actions within the Biotechnology & Pharmaceuticals technology area. These actions are distributed among 3 distinct examiners and 3 distinct art units. KUCKLA, ANNA GRACE is the busiest examiner, currently overseeing 2 busiest examiner pending actions, which is half of the total pending workload.
The distribution across 3 distinct art units indicates that the portfolio covers a relatively broad range of biotechnology subjects. With 3 distinct examiners involved, the company must manage multiple prosecution styles simultaneously. However, the concentration of 2 busiest examiner pending actions under KUCKLA, ANNA GRACE means that this specific examiner has a disproportionate influence on the portfolio's overall progress compared to the other two examiners.
Practitioners should analyze the 4 pending office actions to identify any common technical rejections that might span the 3 distinct art units. Because KUCKLA, ANNA GRACE handles 2 of these actions, their specific feedback will be the most significant indicator of the portfolio's health. The use of 3 distinct examiners provides some variety in prosecution experience, which can be used to compare different examiner approaches to similar biotechnology claims.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §102 only | 2 (50%) |
| Double-patenting + other | 2 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KUCKLA, ANNA GRACE | 2 | 53.8% | +51.3% |
| HASTINGS, ALISON AZAR | 1 | 62.5% | +42.1% |
| BELL, SARA ELIZABETH | 1 | 68.8% | +38.2% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17923707 | AKT3 MODULATORS | HASTINGS, ALISON AZAR | 89d overdue |
| 17923779 | AKT3 MODULATORS | KUCKLA, ANNA GRACE | — |
| 17923837 | AKT3 MODULATORS | KUCKLA, ANNA GRACE | — |
| 17923811 | AKT3 MODULATORS | BELL, SARA ELIZABETH | — |
| Art Unit | Apps |
|---|---|
| 1626 | 2 |
| 1627 | 1 |
| 1625 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17923779 | AKT3 MODULATORS | KUCKLA, ANNA GRACE | 1626 | §102 | Final Rejection | — | Pending | Nov 07, 2022 |
| 17923707 | AKT3 MODULATORS | HASTINGS, ALISON AZAR | 1627 | §102§103§112DP | Final Rejection | 89d overdue | Pending | Nov 07, 2022 |
| 17923837 | AKT3 MODULATORS | KUCKLA, ANNA GRACE | 1626 | §102 | Final Rejection | — | Pending | Nov 07, 2022 |
| 17923811 | AKT3 MODULATORS | BELL, SARA ELIZABETH | 1625 | §102DP | Final Rejection | — | Pending | Nov 07, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialGeorgiamune Inc. has 4 pending office actions as of October 2026, spread across 3 art units and 3 examiners.
Anna Grace Kuckla has the most, with 2 of Georgiamune Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
